单元突触抑制对腹部特格мента区域多巴胺神经元中尖端时间的影响
Matthew H Higgs1, Michael J Beckstead2
1Aging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 matthew-higgs@omrf.org.
eNeuro
|July 5, 2024
概括
抑制性输入显著改变多巴胺神经元发射模式. 非同步抑制在调节神经元活动和产生暂停方面比同步抑制更有效,影响强化过程.
科学领域:
- 神经科学是一个神经科学.
- 计算神经科学是一种神经科学.
背景情况:
- 中脑多巴胺神经元由于交汇的突触输入而表现出复杂的发射模式.
- 了解抑制输入如何塑造多巴胺神经元活动对于理解强化学习至关重要.
研究的目的:
- 为了研究单个和多个抑制输入对腹膜区域 (VTA) 多巴胺神经元发射的影响.
- 模拟抑制后突触导电量对尖峰时间和发射速度的影响.
主要方法:
- 使用电和光学刺激测量了单元抑制后突触电流.
- 确定了相位重置曲线和GABA (A) 受体逆转潜力.
- 开发了VTA多巴胺神经元的相振荡器模型,结合实验数据.
主要成果:
- 抑制后突触导电量的时间极大地影响了峰值的时间.
- 非同步抑制在调节火速和规律性方面比同步抑制更有效.
- 抑制输入的小波动可以产生高度可变的发射模式,包括与强化相关的暂停.
结论:
- 抑制性突触输入变异性在塑造多巴胺神经元发射模式方面发挥着关键作用.
- 异步抑制有效地改变了VTA多巴胺神经元的活动,可能是潜在的强化机制.
相关概念视频
Excitatory and Inhibitory Effects of Neurotransmitters
9.9K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.9K
Integration of Synaptic Events
1.5K
Synaptic integration mainly includes the summation of graded potentials. Graded potentials, regardless of their type, cause subtle alterations in membrane voltage, resulting in either depolarization or hyperpolarization. These incremental changes, when combined or summed, can propel the neuron toward its threshold. Consider, for example, a membrane experiencing a +15 mV shift, causing it to depolarize from -70 mV to -55 mV. In this scenario, graded potentials govern the membrane's ability to...
1.5K
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K


